CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer-Reference-Cited by-同舟云学术

CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer

Published:2015-12-10 Issue:8 Volume:138 Page:1971-1981
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Huynh Phuong T.¹,Beswick Ellen J.²,Coronado Yun A.¹,Johnson Paul³,O'Connell Malaney R.⁴,Watts Tammara⁵,Singh Pomila⁴,Qiu Suimin⁶,Morris Katherine⁷,Powell Don W.¹⁴⁸,Pinchuk Irina V.¹⁸⁹

Affiliation:

1. Departments of Internal Medicine; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

2. Department of Molecular Genetics; University of New Mexico; Albuquerque NM

3. Departments of Surgery; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

4. Departments of Neuoroscience and Cell Biology; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

5. Departments of Otolaryngology; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

6. Departments of Pathology; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

7. Department of Surgery; University of New Mexico; Albuquerque NM

8. Institute of Translational Science at University of Texas Medical Branch; Galveston TX

9. Departments of Microbiology and Immunology; Institute of Translational Science at University of Texas Medical Branch; Galveston TX

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

NCI

NCAT

ACS

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers;Gill;Br J Cancer,2014

2. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development;Waldner;Semin Immunol,2014

3. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer;Belluco;Ann Surg Oncol,2000

4. Principles of interleukin (IL)−6-type cytokine signalling and its regulation;Heinrich;Biochem J,2003

5. IL-6 biology: implications for clinical targeting in rheumatic disease;Calabrese;Nat Rev Rheumatol,2014

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer;Annual Review of Physiology;2024-02-12

2. Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn’s Disease;Journal of Crohn's and Colitis;2024-01-15

3. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts;Hepatoma Research;2023-11-03

4. AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages;Cell Reports;2023-09

5. How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells;World Journal of Stem Cells;2023-05-26